Istituto di Ricerche Farmacologiche Mario Negri | Italy
Dr. Giuseppe Remuzzi, an Italian physician and researcher with long career in nephrology and internal medicine, obtained his M.D. cum laude from the University of Pavia in 1974, followed by specializations in Laboratory and Clinical Hematology (1977) and in Clinical Nephrology (cum laude, 1980) from University of Milan. He held positions as Resident Fellow in Internal Medicine at Ospedale Briolini, Gazzaniga; then Assistant Professor and later Associate Professor in Nephrology and Dialysis at Ospedali Riuniti, Bergamo; he also did research fellowships in the U.K. at Babraham (Cambridge) and Guy’s Hospital Medical School (London). His research broadly spans kidney disease, clinical nephrology, molecular‐and pathophysiological mechanisms of renal injury, and translational studies. According to Google Scholar, Remuzzi has an h-index of 232, has published thousands of scholarly documents, and has received on the order of ~448,630 citations. Other sources such as Research.com report his Medicine discipline D-index ~209 with ~282,315 citations in Medicine alone. Throughout his career he has contributed numerous papers in high‐impact journals, guiding advances in diagnostics, treatments, and understanding of kidney function and disease, and remains a leading figure in Italian and international nephrology research.
Featured Publications:
Perico, L., Casiraghi, F., Benigni, A., & Remuzzi, G. (2025). Is there a place for engineered immune cell therapies in autoimmune diseases? Trends in Molecular Medicine. Advance online publication.
Anandh, U., Anders, H.-J., Bacchetta, J., Johnson, D. W., Luyckx, V., Remuzzi, G., Rodriguez-Iturbe, B., Susztak, K., Tuttle, K., & Yanagita, M. (2025). Two decades of nephrology research: Progress and future challenges. Nature Reviews Nephrology. Advance online publication.
Ghaddar, M., Caravaca-Fontán, F., Praga, M., Fernández-Juárez, G., Lomax-Browne, H. J., Cook, H. T., Daina, E., Noris, M., Remuzzi, G., Induruwage, D., & colleagues. (2025). Clinical and histologic predictors of kidney outcomes in C3 glomerulopathy and idiopathic membranoproliferative GN. Clinical Journal of the American Society of Nephrology. Advance online publication.
Pezzotta, A., Perico, L., Morigi, M., Corna, D., Locatelli, M., Zoja, C., Benigni, A., Remuzzi, G., Imberti, B., & colleagues. (2025). Correction: Low nephron number induced by maternal protein restriction is prevented by nicotinamide riboside supplementation depending on sirtuin 3 activation. Cells, 14(17), 1328.
Zoccali, C., Provenzano, P. F., Tripepi, G., Carrara, F., Mallamaci, F., Perna, A., Delanaye, P., Ruggenenti, P., & Remuzzi, G. (2025). Reliability of GFR estimated by creatinine-based formulas in moderate-to-severe proteinuria. Clinical Journal of the American Society of Nephrology. Advance online publication.
Zoccali, C., Mallamaci, F., Lightstone, L., Jha, V., Pollock, C., Tuttle, K., Kotanko, P., Wiecek, A., Anders, H.-J., Remuzzi, G., & colleagues. (2024). A new era in the science and care of kidney diseases. Nature Reviews Nephrology, 20(7), 439–453.